Giant Cell Glioblastoma

subtype

Identifier: CI-CAN-00000930
Entity page: /cancer/giant-cell-glioblastoma ↗
Edges: 136

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Giant Cell Glioblastoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 36show all (up to 200)
→ investigated in trials for	Temozolomidesmall molecule 21 trials (1 active) · roll-up of the cancer and its descendants	—	—	Giant Cell Glioblastoma	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody

Giant Cell Glioblastoma studied in …STUDIED_INderived10 of 100show all (up to 200)
→ studied in	NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Adult Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05218408Phase 1/Phase 2 · withdrawn CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06806228Phase 1 · suspended Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04482933Phase 2 · withdrawn HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02709226Phase 1 · completed Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01165632early Phase 1 · completed Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Adult Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02186509Phase 1 · completed Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Adult Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01894061Phase 2 · completed NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Adult Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01149850Phase 2 · completed Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03027388Phase 2 · completed Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 100 trials mapped (1 active)	—	—	Giant Cell Glioblastoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains